ArticleBMC infectious diseases2026
Bacteremia complicating urinary tract infections in hospitalized patients in a tertiary care hospital in Palestine, retrospective study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBloodstream infections secondary to urinary tract infections (UTIs) are associated with prolonged hospital stays, increased complications, higher costs, and elevated mortality rates. Previous studies reported mortality rates ranging from 25% to 60%. To our knowledge, no studies have yet investigated bloodstream infections secondary to UTIs in Palestine. Therefore, we conducted this study to identify common risk factors associated with bloodstream infections secondary to UTIs, and to describe their clinical progression, outcomes, and mortality.
methodsThis retrospective cross-sectional study was conducted at An-Najah National University Hospital ( ANNUH) and included 140 adult patients aged 19–90 years who had concurrent positive urine and blood cultures for the same pathogen. Demographic, microbiological, and laboratory data were collected from 2018 to 2023. Mortality outcomes were assessed and analyzed in correlation with these findings.
resultsA total of 140 patients were enrolled in the study. Of the isolates, 71.4% were bacterial and 28.6% were fungal. Candida species were the most common isolates (28.6%), followed by Escherichia coli (26.4%). Among the participants, 43% died. Candida bloodstream infection, mechanical ventilation, admission to the intensive care unit, and a history of chronic pulmonary disease were significantly associated with higher mortality. Laboratory parameters including low white blood cell count, hemoglobin, and platelets were also associated with death.
conclusionThis study is the first in Palestine to examine bloodstream infections secondary to UTIs. The findings indicate an epidemiologic shift from predominantly Escherichia coli to Candida species. Mortality was significantly associated with Candida bloodstream infection and risk factors such as intensive care unit admission, mechanical ventilation, and central line use. Ongoing surveillance and periodic monitoring of resistance patterns are essential to improve outcomes and guide empirical therapy. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.